Literature DB >> 19468997

Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.

Massimo-C Fantini1, Francesco Pallone, Giovanni Monteleone.   

Abstract

Spondyloarthropathies (SpA) are commonly observed extra-intestinal manifestations of both Crohn's disease (CD) and ulcerative colitis (UC), the two major forms of inflammatory bowel diseases (IBD). However, the immunological link between these two clinical entities is still poorly understood. Several lines of evidence indicate that SpA may originate from the relocation to the joints of the immune process primarily induced in the gut. The transfer of the intestinal inflammatory process into the joints implicates that immune cells activated in the gut-draining lymph nodes can localize, at a certain point of the intestinal disease, either into the gut or into the joints. This is indicated by the overlapping expression of adhesion molecules observed on the surface of intestinal and synovial endothelial cells during inflammation. Moreover bacterial antigens and HLA-B27 expression may be implicated in the reactivation of T cells at the articular level. Finally, accumulating evidence indicates that a T helper 17 cell-mediated immune response may contribute to IBD and IBD-related SpA with a crucial role played by tumor necrosis factor-alpha in CD and to a lesser extent in UC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468997      PMCID: PMC2686905          DOI: 10.3748/wjg.15.2472

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  59 in total

1.  Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules.

Authors:  M Salmi; S Jalkanen
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.

Authors:  J Braun; J Brandt; J Listing; A Zink; R Alten; W Golder; E Gromnica-Ihle; H Kellner; A Krause; M Schneider; H Sörensen; H Zeidler; W Thriene; J Sieper
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

3.  Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Authors:  Filip Van Den Bosch; Elli Kruithof; Dominique Baeten; Annemie Herssens; Filip de Keyser; Herman Mielants; Eric M Veys
Journal:  Arthritis Rheum       Date:  2002-03

4.  Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease.

Authors:  Sophia Steer; Hugh Jones; Jane Hibbert; Elli Kondeatis; Robert Vaughan; Jeremy Sanderson; Terence Gibson
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

5.  Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins.

Authors:  Manuel Ramos; Iñaki Alvarez; Laura Sesma; Antoine Logean; Didier Rognan; José A López de Castro
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

6.  HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.

Authors:  Simon Kollnberger; Lucy A Bird; Matthew Roddis; Cecile Hacquard-Bouder; Hiromi Kubagawa; Helen C Bodmer; Maxime Breban; Andrew J McMichael; Paul Bowness
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 7.  Ankylosing spondylitis: a beta2m-deposition disease?

Authors:  Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Trends Immunol       Date:  2003-02       Impact factor: 16.687

Review 8.  Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis.

Authors:  Wolfgang Kuon; Joachim Sieper
Journal:  Rheum Dis Clin North Am       Date:  2003-08       Impact factor: 2.670

9.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

Authors:  Bengt Johansson-Lindbom; Marcus Svensson; Marc-André Wurbel; Bernard Malissen; Gabriel Márquez; William Agace
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

View more
  16 in total

1.  NSAID-induced deleterious effects on the proximal and mid small bowel in seronegative spondyloarthropathy patients.

Authors:  Mihai Rimbaş; Mădălina Marinescu; Mihail Radu Voiosu; Cristian Răsvan Băicuş; Simona Caraiola; Adriana Nicolau; Doina Niţescu; Georgeta Camelia Badea; Magda Ileana Pârvu
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

Review 2.  Importance of intestinal microenvironment in development of arthritis. A systematic review.

Authors:  Anna Bazsó; Péter Szodoray; Gábor Sütő; Yehuda Shoenfeld; Gyula Poór; Emese Kiss
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

4.  Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis.

Authors:  Marianne A Andretta; Thaís D Vieira; Renato Nishiara; Thelma L Skare
Journal:  Rheumatol Int       Date:  2011-02-09       Impact factor: 2.631

5.  Salmonella enterica induces joint inflammation and expression of interleukin-17 in draining lymph nodes early after onset of enterocolitis in mice.

Authors:  Mariángeles Noto Llana; Sebastián Hernán Sarnacki; María Victoria Vázquez; Alejandra Sonia Gartner; Mónica Nancy Giacomodonato; María Cristina Cerquetti
Journal:  Infect Immun       Date:  2012-04-09       Impact factor: 3.441

6.  Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Authors:  M Arvonen; P Vähäsalo; S Turunen; H M Salo; M Mäki; K Laurila; O Vaarala; T J Karttunen
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

7.  Inflammatory bowel disease-associated spondyloarthropathies.

Authors:  Walter Fries
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

8.  A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas.

Authors:  Tsuyoshi Kobashigawa; Yuki Nanke; Masakazu Takazoe; Kuniko Iihara; Hisashi Yamanaka; Shigeru Kotake
Journal:  Clin Med Insights Case Rep       Date:  2014-04-27

Review 9.  Enteropathic spondyloarthritis: from diagnosis to treatment.

Authors:  Rosario Peluso; Matteo Nicola Dario Di Minno; Salvatore Iervolino; Francesco Manguso; Giuseppina Tramontano; Pasquale Ambrosino; Carmela Esposito; Antonella Scalera; Fabiana Castiglione; Raffaele Scarpa
Journal:  Clin Dev Immunol       Date:  2013-04-15

10.  Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.

Authors:  Lovro Lamot; Fran Borovecki; Lana Tambic Bukovac; Mandica Vidovic; Marija Perica; Kristina Gotovac; Miroslav Harjacek
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.